4.1 Common adverse event |
1 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Totals not selected |
4.1.1 Skin irritation |
1 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Totals not selected |
4.1.2 Pruritus |
1 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Totals not selected |
4.1.3 Erythema |
1 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Totals not selected |
4.1.4 Contact dermatitis |
1 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Totals not selected |
4.1.5 Skin hyperpigmentation |
1 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Totals not selected |
4.1.6 Folliculitis |
1 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Totals not selected |
4.2 Complete response |
1 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Subtotals only |
4.3 Objective response rate |
1 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Subtotals only |